nach oben

Erschienen in:

02.06.2021 | Original Article

Identifying potential metabolic tissue biomarkers for papillary thyroid cancer in different iodine nutrient regions

verfasst von: Qihao Sun, Hongjian Zhao, Zhiyong Liu, Fengqian Wang, Qian He, Cheng Xiu, Lunhua Guo, Qiushi Tian, Lijun Fan, Ji Sun, Dianjun Sun

Erschienen in: Endocrine | Ausgabe 3/2021

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To investigate the applicability of metabolomics to select thyroid cancer-associated biomarkers and discover the effects of iodine on metabolic changes in thyroid cancer.

Methods

In this study, a total of 33 papillary thyroid cancer (PTC) patients from areas with iodine excess and 32 PTC patients from areas with adequate iodine were recruited, and their cancerous tissue and paracancerous tissue were collected. These specimens were analyzed by ultra-performance liquid chromatography-quadrupole time-of-flight mass spectrometry (UPLC/QTOF/MS) in conjunction with multivariate statistical analysis.

Results

Good separations were obtained for PTC tissue vs. paracancerous tissue, and 15 metabolites, including L-octanoylcarnitine, N-arachidonoylglycine, and others were found to be disturbed in PTC tissue. Moreover, the metabolic profile presented considerable separation between PTC tissue from different iodine areas, and 15 metabolomic biomarkers were found to be differentially expressed. Among them, 10 metabolites, including arachidonoylcarnitine and LysoPCs, were related to thyroid cancer and excess iodine. These biomarkers play a role in arachidonic acid metabolism pathways and others. In addition, biomarkers such as 3,5-tetradecadiencarnitine and oxidized glutathione were significantly correlated with thyroid function, and biomarkers such as L-octanoylcarnitine and arachidonic acid were significantly correlated with the clinical characteristics of PTC.

Conclusions

Distinct differences in metabolic profiles were found to exist between PTCs from areas with different levels of iodine nutrition. The identified biomarkers have significant potential for diagnosing PTC and investigating its underlying mechanisms.

Nur mit Berechtigung zugänglich

C.M. Kitahara, J.A. Sosa, The changing incidence of thyroid cancer. Nat. Rev. Endocrinol. 12(11), 646–653 (2016)PubMedCrossRef

M. Pusztaszeri, M. Auger, Update on the cytologic features of papillary thyroid carcinoma variants. Diagn. Cytopathol. 45(8), 714–730 (2017)PubMedCrossRef

M. Akıncı, S.P. Bulut, F. Erözgen et al. Predictive value of fine needle aspiration biopsy of axillary lymph nodes in preoperative breast cancer staging. Ulus. Cerrahi Derg. 32(3), 191–6 (2016)PubMedPubMedCentral

J.H. An, K.H. Song, S.K. Kim et al. RAS mutations in indeterminate thyroid nodules are predictive of the follicular variant of papillary thyroid carcinoma. Clin. Endocrinol. 82(5), 760–6 (2015)CrossRef

J. Li, J. Liu, X. Yu, X. Bao, L. Qian, BRAFv600e mutation combined with thyroglobulin and fine-needle aspiration in diagnosis of lymph node metastasis of papillary thyroid carcinoma. Pathol. Res. Pract. 214(11), 1892–1897 (2018)PubMedCrossRef

E.G. Armitage, M. Ciborowski, Applications of metabolomics in cancer studies. Adv. Exp. Med. Biol. 965, 209–234 (2017)PubMedCrossRef

A.K. Kaushik, R.J. DeBerardinis, Applications of metabolomics to study cancer metabolism. Biochim. Biophys. Acta Rev. Cancer 1870(1), 2–14 (2018)PubMedPubMedCentralCrossRef

G. Hoang, S. Udupa, A. Le, Application of metabolomics technologies toward cancer prognosis and therapy. Int. Rev. Cell Mol. Biol. 347, 191–223 (2019)PubMedCrossRef

X. Shang, X. Zhong, X. Tian, Metabolomics of papillary thyroid carcinoma tissues: potential biomarkers for diagnosis and promising targets for therapy. Tumour Biol. 37(8), 11163–75 (2016)PubMedCrossRef

10.

J. Chen, Q. Hu, H. Hou et al. Metabolite analysis-aided diagnosis of papillary thyroid cancer. Endocr. Relat. Cancer 26(12), 829–841 (2019)PubMedCrossRef

11.

C.T. Shen, Y. Zhang, Y.M. Liu et al. A distinct serum metabolic signature of distant metastatic papillary thyroid carcinoma. Clin. Endocrinol. 87(6), 844–852 (2017)CrossRef

12.

Y. Li, M. Chen, C. Liu et al. Metabolic changes associated with papillary thyroid carcinoma: a nuclear magnetic resonance-based metabolomics study. Int. J. Mol. Med. 41(5), 3006–3014 (2018)PubMed

13.

M.B. Zimmermann, K. Boelaert, Iodine deficiency and thyroid disorders. Lancet Diabetes Endocrinol. 3(4), 286–95 (2015)PubMedCrossRef

14.

P. Laurberg, S.B. Nøhr, K.M. Pedersen et al. Thyroid disorders in mild iodine deficiency. Thyroid 10(11), 951–63 (2000)PubMedCrossRef

15.

F. Delange, H. Bürgi, Iodine deficiency disorders in Europe. Bull. World Health Organ 67(3), 317–25 (1989)PubMedPubMedCentral

16.

Y. Guo, J. Zynat, Z. Xu et al. Iodine nutrition status and thyroid disorders: a cross-sectional study from the Xinjiang Autonomous Region of China. Eur. J. Clin. Nutr. 70(11), 1332–1336 (2016)PubMedCrossRef

17.

O. Ali, Iodine deficiency disorders: a public health challenge in developing countries. Nutrition 11(5 Suppl), 517–20 (1995)PubMed

18.

Q.J. Yang, J.R. Zhao, J. Hao et al. Serum and urine metabolomics study reveals a distinct diagnostic model for cancer cachexia. J. Cachexia Sarcopenia Muscle 9(1), 71–85 (2018)PubMedCrossRef

19.

T. Chen, P. He, Y. Tan, D. Xu, Biomarker identification and pathway analysis of preeclampsia based on serum metabolomics. Biochem. Biophys. Res. Commun. 485(1), 119–125 (2017)PubMedCrossRef

20.

M. Chen, M. Shen, Y. Li et al. GC-MS-based metabolomic analysis of human papillary thyroid carcinoma tissue. Int. J. Mol. Med. 36(6), 1607–14 (2015)PubMedCrossRef

21.

K.M. Kim, B.H. Jung, D.S. Lho, W.Y. Chung, K.J. Paeng, B.C. Chung, Alteration of urinary profiles of endogenous steroids and polyunsaturated fatty acids in thyroid cancer. Cancer Lett. 202(2), 173–9 (2003)PubMedCrossRef

22.

Z.H. Wen, Y.C. Su, P.L. Lai et al. Critical role of arachidonic acid-activated mTOR signaling in breast carcinogenesis and angiogenesis. Oncogene 32(2), 160–70 (2013)PubMedCrossRef

23.

S. Wang, J. Xie, H. Li, K. Yang, Differences of polyunsaturated fatty acid in patients with colorectal cancer and healthy people. J. Cancer Res. Ther. 11(2), 459–63 (2015)PubMedCrossRef

24.

D.K. Nomura, J.Z. Long, S. Niessen, H.S. Hoover, S.W. Ng, B.F. Cravatt, Monoacylglycerol lipase regulates a fatty acid network that promotes cancer pathogenesis. Cell 140(1), 49–61 (2010)PubMedPubMedCentralCrossRef

25.

W.C. Chang, J. Nakao, H. Orimo, S. Murota, Effects of reduced glutathione on the 12-lipoxygenase pathways in rat platelets. Biochem J. 202(3), 771–6 (1982)PubMedPubMedCentralCrossRef

26.

Y.S. Lin, Y.C. Shen, C.Y. Wu et al. Danshen improves survival of patients with breast cancer and dihydroisotanshinone i induces ferroptosis and apoptosis of breast cancer cells. Front. Pharm. 10, 1226 (2019)CrossRef

27.

J. Liu, M. Liu, H. Zhang et al. Exploring cysteine regulation in cancer cell survival with a highly specific “Lock and Key” fluorescent probe for cysteine. Chem. Sci. 10(43), 10065–10071 (2019)PubMedPubMedCentralCrossRef

28.

E.S. Pizer, C. Jackisch, F.D. Wood, G.R. Pasternack, N.E. Davidson, F.P. Kuhajda, Inhibition of fatty acid synthesis induces programmed cell death in human breast cancer cells. Cancer Res. 56(12), 2745–7 (1996)PubMed

29.

S. Qiao, P. Pennanen, N. Nazarova, Y.R. Lou, P. Tuohimaa, Inhibition of fatty acid synthase expression by 1alpha,25-dihydroxyvitamin D3 in prostate cancer cells. J. Steroid Biochem. Mol. Biol. 85(1), 1–8 (2003)PubMedCrossRef

30.

M. Crous-Bou, G. Rennert, R. Salazar et al. Genetic polymorphisms in fatty acid metabolism genes and colorectal cancer. Mutagenesis 27(2), 169–76 (2012)PubMedPubMedCentralCrossRef

31.

N. Khan, P.P. Shah, D. Ban et al. Solution structure and functional investigation of human guanylate kinase reveals allosteric networking and a crucial role for the enzyme in cancer. J. Biol. Chem. 294(31), 11920–11933 (2019)PubMedPubMedCentralCrossRef

32.

H.I. Wettersten, A.A. Hakimi, D. Morin, C. Bianchi, M.E. Johnstone, D.R. Donohoe, J.F. Trott, O.A. Aboud, S. Stirdivant, B. Neri, R. Wolfert, B. Stewart, R. Perego, J.J. Hsieh, R.H. Weiss, Grade-dependent metabolic reprogramming in kidney cancer revealed by combined proteomics and metabolomics analysis. Cancer Res. 75(12), 2541–2552 (2015)PubMedPubMedCentralCrossRef

33.

S. Ganti, S.L. Taylor, K. Kim, C.L. Hoppel, L. Guo, J. Yang, C. Evans, R.H. Weiss, Urinary acylcarnitines are altered in human kidney cancer. Int. J. Cancer 130(12), 2791–2800 (2012)PubMedCrossRef

34.

A. Al-Bakheit, M. Traka, S. Saha, R. Mithen, A. Melchini, Accumulation of palmitoylcarnitine and its effect on pro-inflammatory pathways and calcium influx in prostate cancer. Prostate 76(14), 1326–37 (2016)PubMedPubMedCentralCrossRef

35.

S. Wahl, Z. Yu, M. Kleber, P. Singmann, C. Holzapfel, Y. He, K. Mittelstrass, A. Polonikov, C. Prehn, W. Römisch-Margl, J. Adamski, K. Suhre, H. Grallert, T. Illig, R. Wang-Sattler, T. Reinehr, Childhood obesity is associated with changes in the serum metabolite profile. Obes. Facts 5(5), 660–70 (2012)PubMedCrossRef

36.

M. Kang, H.J. Yoo, M. Kim, M. Kim, J.H. Lee, Metabolomics identifies increases in the acylcarnitine profiles in the plasma of overweight subjects in response to mild weight loss: a randomized, controlled design study. Lipids Health Dis. 17(1), 237 (2018)PubMedPubMedCentralCrossRef

37.

F.Q. Huang, J. Li, L. Jiang et al. Serum-plasma matched metabolomics for comprehensive characterization of benign thyroid nodule and papillary thyroid carcinoma. Int. J. Cancer 144(4), 868–876 (2019)PubMedCrossRef

38.

J.L. Rabinowitz, C.J. Tavares, Iodinated phospholipids and the in vitro iodination of proteins of dog thyroid gland. Biochem. J. 168(2), 155–60 (1977)PubMedPubMedCentralCrossRef

39.

N.G. Psihogios, I.F. Gazi, M.S. Elisaf, K.I. Seferiadis, E.T. Bairaktari, Gender-related and age-related urinalysis of1 healthy subjects by NMR-based metabonomics. NMR Biomed. 21(3), 195–207 (2008)PubMedCrossRef

40.

D. Chen, L. Fang, H. Li, C. Jin, The effects of acetaldehyde exposure on histone modifications and chromatin structure in human lung bronchial epithelial cells. Environ. Mol. Mutagen 59(5), 375–385 (2018)PubMedPubMedCentralCrossRef

41.

Y.S. Lin, Y.C. Shen, C.Y. Wu et al. Danshen improves survival of patients with breast cancer and dihydroisotanshinone I induces ferroptosis and apoptosis of breast cancer cells. Front. Pharmacol. 10, 1226 (2019)PubMedPubMedCentralCrossRef

42.

Yu. J, Shan. Z, Chong. W, et al. Vitamin E ameliorates iodine-induced cytotoxicity in thyroid. J. Endocrinol. 209(3), 299–306 (2011).CrossRef

Titel: Identifying potential metabolic tissue biomarkers for papillary thyroid cancer in different iodine nutrient regions
verfasst von: Qihao Sun
Hongjian Zhao
Zhiyong Liu
Fengqian Wang
Qian He
Cheng Xiu
Lunhua Guo
Qiushi Tian
Lijun Fan
Ji Sun
Dianjun Sun
Publikationsdatum: 02.06.2021
Verlag: Springer US
Erschienen in: Endocrine / Ausgabe 3/2021
Print ISSN: 1355-008X
Elektronische ISSN: 1559-0100
DOI: https://doi.org/10.1007/s12020-021-02773-3

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

18.04.2024 | Wirbelsäulenmetastase | Nachrichten

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Identifying potential metabolic tissue biomarkers for papillary thyroid cancer in different iodine nutrient regions

Abstract

Purpose

Methods

Results

Conclusions

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Stereotaktische Radiatio schlägt konventionelle Bestrahlung

Denken Sie bei starker Blutung auch an die Hemmkörper-Hämophilie

Adjuvante Brustkrebstherapie: Doppelt hält besser

Delir kann Demenz begünstigen

Update Innere Medizin

Springer Medizin

Abstract

Purpose

Methods

Results

Conclusions

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 3/2021

Irinotecan-based chemotherapy in extrapulmonary neuroendocrine carcinomas: survival and safety data from a multicentric Italian experience

Spectrum of mitochondrial genomic variation in parathyroid neoplasms

Efficacy and safety of different basal and prandial insulin analogues for the treatment of type 2 diabetes: a network meta-analysis of randomized controlled trials

Different management of adrenocortical carcinoma in children compared to adults: is it time to share guidelines?

Pediatric multidisciplinary weight management—how can we improve further?

Reduction of impulsivity in patients receiving deep transcranial magnetic stimulation treatment for obesity

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Stereotaktische Radiatio schlägt konventionelle Bestrahlung

Denken Sie bei starker Blutung auch an die Hemmkörper-Hämophilie

Adjuvante Brustkrebstherapie: Doppelt hält besser

Delir kann Demenz begünstigen

Update Innere Medizin